type="text/javascript">

Johnson & Johnson wins reversal of $1.2 billion Arkansas Risperdal judgment

Posted On 31 Mar 2014
By :

Johnson & Johnson on Thursday won the reversal by the Arkansas Supreme Court of a roughly $1.2 billion judgment in a lawsuit accusing the company of improperly marketing the anti-psychotic drug Risperdal.

Read the source article at reuters.com

About the Author

Leave a Reply

*